Table 2.
Drug | Management |
---|---|
Decreases voriconazole interactions | |
Rifampin | contraindicated |
Rifabutin | contraindicated |
Phenytoin | monitoring |
Carbamazepine | contraindicated |
Long-acting barbiturates | contraindicated |
Ritonavir | contraindicated |
Efavirenz | contraindicated |
Increases in concentration by voriconazole | |
Sirolimus | contraindicated |
Rifabutin | contraindicated |
Efavirenz | contraindicated |
Quinidine | contraindicated |
Tacrolimus | monitoring |
Cyclosporine | monitoring |
Omeprazole | reduce dose by half |
Warfarin | monitoring |
Methadone | reduce dose |
Likely increases in concentration by voriconazole | |
Ergot alkaloids | contraindicated |
Pimozide | contraindicated |
Sulfonylureas | monitoring |
HMG-CoA reductase inhibitors | monitoring |
Vinca alkaloids | monitoring |
Calcium channel blockers | monitoring |
Benzodiazepines | monitoring |
Prednisolone | monitoring |
HIV protease inhibitors, not indinavir | monitoring |